Pharmacies

Our attorneys possess an intimate knowledge of Florida’s pharmacy laws and regulations, including the Florida Pharmacy Act (Chapter 465, F.S.) , the Florida Drug and Cosmetic Act (Chapter 499, F.S.) , the Florida Controlled Substances Act (Chapter 893, F.S.) , and the detailed rules of the Florida Board of Pharmacy (FAC 64B16). We are constantly monitoring legislative changes, Florida Board of Pharmacy pronouncements , and enforcement trends from agencies like the Agency for Health Care Administration (AHCA) to ensure your pharmacy is always prepared.

From the initial dream of opening your pharmacy to navigating daily operational complexities, managing growth, ensuring robust compliance, and executing strategic transactions, we offer a full spectrum of legal services. We are your partners for the entire lifecycle of your pharmacy business, mirroring the comprehensive approach sought by discerning clients.

We believe that informed clients make the best decisions. Our commitment extends beyond legal representation to educating you on the laws and regulations affecting your practice, empowering you to operate with confidence and foresight. This educational approach is designed to help you become more engaged and knowledgeable about the legal framework impacting your pharmacy.

Our approach is founded on proactive risk management. We work with you to identify potential legal and compliance pitfalls before they become costly problems, implementing strategies to safeguard your license, your finances, and your reputation.

We provide strategic start-up counseling, assisting with the development of legally sound business plans, advising on market entry considerations from a compliance perspective, and creating a clear roadmap for your pharmacy’s launch. This includes navigating the initial, often daunting, steps required by the Florida Board of Pharmacy and other state and federal agencies. A common, yet often overlooked, challenge for new pharmacies is managing potential delays in the startup process, particularly those related to obtaining a DEA registration. The Florida Board of Pharmacy acknowledges such potential delays and has established specific rules for notification (FAC Rule 64B16-28.1081). For instance, if a pharmacy anticipates a delay in commencing operations after receiving its permit, written notification must be provided to the Board office within 14 days of electing to delay, stating the reasons. Subsequently, within two business days of actually commencing operations, another written notification confirming the start date is required. Failure to commence operations within six months necessitates a further written statement to the Board explaining the reasons and efforts made. Our firm proactively guides clients through these notification requirements, ensuring continued compliance even if unforeseen delays shift the initial timeline. This practical, hands-on approach to managing common startup hurdles demonstrates a level of experience that goes beyond simply filing applications; it anticipates real-world challenges and provides actionable solutions.

Choosing the right legal structure is a foundational decision. We provide in-depth analysis of options such as Sole Proprietorship, Partnership, Limited Liability Company (LLC), S-Corporation, or C-Corporation, explaining the implications for personal liability, taxation, operational flexibility, and administrative requirements specifically for Florida pharmacy owners. Our analysis is tailored to the unique context of a pharmacy, considering factors like the number of owners, investment plans, pharmacist roles within the ownership structure, and long-term exit strategies.

Solidifying relationships and expectations from the start is crucial. We meticulously draft and review all essential formation agreements:

• Partnership Agreements: For pharmacy partnerships, we craft agreements that clearly define capital contributions, profit and loss allocation (Florida’s default under the Revised Uniform Partnership Act is equal allocation among partners, which may not suit all arrangements ), partner authority (where Florida law also defaults to equal authority ), roles and responsibilities, decision-making protocols, comprehensive contingency plans (e.g., addressing the death, disability, or dissociation of a partner), robust dispute resolution mechanisms, and clear dissolution procedures. We ensure these align with Florida law and address unique pharmacy considerations, such as requirements for collaborative practice agreements if partners are pharmacists intending to enter such arrangements.
• Stockholder Agreements (for S-Corps/C-Corps): For incorporated pharmacies, we develop robust stockholder agreements covering shareholder rights and obligations, share issuance and valuation methodologies, critical restrictions on share transfers (including buy-sell provisions, rights of first refusal, and drag-along/tag-along rights), dividend distribution policies, corporate governance structures, decision-making frameworks (e.g., matters requiring supermajority approval), and strategies for shareholder exits, disputes, or events like disability or death of a shareholder. Our agreements are tailored to comply with Florida law, including F.S. §607.0731 concerning voting agreements , and to leverage the benefits of structures like S-corporations, such as pass-through taxation and shareholder asset protection. Specific pharmacist roles and responsibilities within the corporate structure are also considered.
• Bylaws (Corporations) or Operating Agreements (LLCs): We create customized bylaws for corporations and operating agreements for LLCs that serve as your pharmacy’s internal governance playbook. These documents detail management structures (member-managed vs. manager-managed for LLCs), member/shareholder roles and responsibilities, voting rights, allocation and distribution of profits and losses, meeting protocols, record-keeping requirements, and clear procedures for amendments or dissolution. Relying on Florida’s default statutory rules can lead to unintended consequences; a well-drafted operating agreement provides clarity and control.

We ensure the accurate and compliant preparation and filing of your pharmacy’s Articles of Incorporation (for corporations) or Articles of Organization (for LLCs) with the Florida Department of State, a critical step in establishing your legal business entity. All applicants for a pharmacy permit must submit a Certificate of Good Standing or Articles of Organization from the Department of State.

Securing the correct permits and licenses is non-negotiable. We provide comprehensive assistance with:

• Florida Board of Pharmacy Permits: Navigating applications for all Florida pharmacy permit types, including Community , Institutional (Class I, II, Modified II, III) , Nuclear , Special (e.g., Special Closed System Pharmacy, Special Parenteral/Enteral, Special ALF) , Internet , Nonresident Pharmacy , and Nonresident Sterile Compounding. This includes managing fingerprinting and background check requirements (per F.S. 465.022, all owners with 5%+ interest and managers must submit fingerprints ), developing mandatory written policies and procedures for preventing controlled substance dispensing based on fraudulent representations or invalid practitioner-patient relationships (F.S. 465.022(4) ), and ensuring compliance with operational standards like minimum hours of operation (e.g., community pharmacies generally 20 hours/week per FAC 64B16-28.1081 ).
• DEA Registration: Guiding you through new DEA registration applications (DEA Form 224 for retail pharmacies ) and renewals (DEA Form 224a ), ensuring compliance with requirements for each practice location (a separate registration is needed for each principal place of business ) and understanding the interplay between state licensure and federal DEA privileges (DEA registration is contingent on state authority to handle controlled substances ).
• Local Business Licenses: Assisting with obtaining all necessary city and county business licenses and permits.

Becoming an in-network provider is key to patient access and revenue. We assist pharmacies in navigating the often-complex credentialing processes for Medicare, Florida Medicaid (requiring enrollment and adherence to provider requirements to receive reimbursement ), and major commercial payors. This includes understanding specific enrollment qualifications and documentation, such as providing Social Security Numbers for owners/operators as mandated by 26 U.S.C. 6109 for Medicaid enrollment.

We develop and refine comprehensive Policy & Procedure Manuals that are the bedrock of a compliant and safe pharmacy. These manuals are tailored to your specific practice type and cover critical areas such as:

• Prescription Processing and Dispensing: Including interpretation, assessment, certification, and counseling (F.S. 465.003(13) ), and requirements for validating controlled substance prescriptions (FAC 64B16-27.831 ).
• Inventory Management: Especially for controlled substances, including biennial inventory requirements, and records of receipt and disposition (F.S. Chapter 893 ; DEA Pharmacist’s Manual ).
• Patient Counseling: Mandated as an element of dispensing if, in the pharmacist’s professional judgment, it’s necessary (F.S. 465.003(13) ); OBRA ’90 requirements for Medicaid patients.
• Record-Keeping: Maintaining patient records for at least four years (FAC 64B16-27.800 ), prescription records for two years (F.S. 893.04 ), and controlled substance records for at least two years federally. Florida law F.S. 465.022(12) requires prescription drug distribution records be kept for 4 years.
• Emergency Preparedness: Including emergency action plans for fires, power outages, etc..
• Staff Training and Responsibilities: Covering job duties, compliance obligations, and emergency protocols.
• HIPAA Privacy and Security: Implementing safeguards for Protected Health Information (PHI).
• OSHA Standards: Ensuring workplace safety, including hazard communication and bloodborne pathogen precautions.
• Florida Pharmacy Laws & Rules: Adherence to F.S. Chapters 465, 499, 893 and FAC 64B16.
• Specialized Operations: Procedures for centralized prescription filling (F.S. 465.0265 ), common database use (F.S. 465.0266), and specific requirements for Internet Pharmacies (e.g., PDM responsibility for P&P manual, toll-free number ).
• Quality Improvement: Implementing a continuous quality improvement program as per FAC 64B16-27.300. We emphasize the importance of annual reviews and updates to these manuals to reflect changes in law and practice.

We conduct thorough legal reviews of your pharmacy’s operational workflows to identify areas for improved compliance and efficiency. Our IT assessments focus on ensuring your systems and practices meet the stringent requirements of the HIPAA Security Rule, including administrative, physical, and technical safeguards to protect electronic Protected Health Information (ePHI). This includes evaluating data protection measures (firewalls, antivirus software ), secure electronic record systems, access controls (personalized credentials, role-based access ), and staff training on cybersecurity threats. We also advise on physical security measures for your pharmacy, including DEA requirements for controlled substance storage (e.g., TL-30 rated safes bolted to the floor if under 750 lbs, dual-keyed locks ) and Florida-specific laws regarding alarm systems and limiting external access points.

Well-drafted contracts are vital to protecting your pharmacy’s interests. We meticulously review, negotiate, and draft a wide range of agreements:

• Vendor Contracts: Scrutinizing agreements with pharmaceutical suppliers, wholesalers (ensuring compliance with F.S. 499.0121 storage, handling, and recordkeeping ), and service providers to protect the pharmacy’s interests and ensure regulatory compliance.
• Lease Agreements (Rental Leases): Negotiating and reviewing commercial leases for pharmacy premises, addressing unique needs such as security for controlled substances, patient accessibility (ADA compliance), compliance with Florida Drug and Cosmetic Act (F.S. Ch. 499) storage and handling requirements , and implications of FAC Rule 61N-1.001(2)(e) regarding leases in change of ownership scenarios (a new permit may be required if a lessee assumes legal liability for operation ).
• Equipment Purchase and Lease Agreements: Securing favorable and compliant terms for essential pharmacy equipment, from automated dispensing systems to compounding hoods.
• Technology and Software Agreements: Reviewing licensing agreements for pharmacy management systems, Electronic Health Records (EHRs), e-prescribing software, and other technology services. We focus on data ownership, security (HIPAA Business Associate Agreements are critical), liability limitations, service level agreements (SLAs), and interoperability.

We provide comprehensive legal support for the acquisition or sale of pharmacy properties. This includes conducting due diligence on the property, negotiating purchase and sale agreements, ensuring zoning compliance for pharmacy operations, advising on ADA accessibility requirements, and navigating specific facility requirements mandated by Florida law and the Board of Pharmacy for permitted establishments.

Your staff is your most valuable asset and also a significant area of potential legal risk. We help you manage your workforce compliantly and effectively:

• Employment Agreements: Drafting and reviewing employment contracts for pharmacists, pharmacy technicians, and other staff, clearly outlining compensation, duties, benefits, confidentiality obligations, and enforceable restrictive covenants (e.g., non-competes, non-solicitation) in line with Florida law.
• Employee Handbooks: Creating comprehensive, Florida-compliant employee handbooks. These are crucial for setting expectations and as a defense in potential disputes. Key provisions include: clear at-will employment disclaimers (stating the handbook is not a contract and policies can change ), drug and alcohol testing policies (including guidance on handling medical marijuana cardholders and the implications of cases like Giambrone v. Hillsborough County regarding reasonable suspicion testing and accommodation ), Family and Medical Leave Act (FMLA) policies (and awareness of local ordinances like Miami-Dade County’s expansion for grandparent care ), updated Florida child labor law provisions (restrictions eased for 16- and 17-year-olds in 2024 ), procedures for reporting wage/hour concerns, policies on introductory periods (which can affect unemployment claims if notice is given within the first seven days of work ), and obtaining signed employee acknowledgments of receipt and understanding (with translations if a significant portion of the workforce is not proficient in English ).
• Employment Classifications: Advising on the correct classification of your pharmacy staff (e.g., pharmacists often qualify for the “learned professional” exemption from overtime under the Fair Labor Standards Act (FLSA) if salary and duties tests are met , while pharmacy technicians are typically non-exempt) to ensure proper payment of wages and overtime, and to avoid costly misclassification penalties under federal and Florida law.
• Policy Drafting and Review (HR-specific): Developing and updating essential HR policies covering anti-discrimination, anti-harassment (including sexual harassment prevention), leaves of absence, workplace conduct, social media use, and more, all tailored to the unique environment and risks of a pharmacy.
• Workplace Investigations: Providing step-by-step guidance on conducting thorough, fair, objective, and legally defensible internal investigations into employee complaints (e.g., discrimination, harassment, policy violations, suspected drug diversion). This includes advice on selecting an impartial investigator, maintaining confidentiality to the extent possible, documenting all steps, interviewing relevant parties (complainant, accused, witnesses), and understanding the procedures and jurisdiction of the Florida Commission on Human Relations (FCHR). Timeliness and thoroughness are critical to avoid claims of prejudice or inadequate response.
• Employment Disputes & Termination Reviews: Advising on best practices for disciplinary actions and employee terminations in Florida, which is an at-will employment state. This includes documenting legitimate, non-discriminatory reasons for termination (e.g., poor performance, policy violations, insubordination ) and understanding exceptions to at-will employment, such as terminations that violate anti-discrimination laws or constitute retaliation for exercising protected rights (e.g., FMLA leave, filing a workers’ compensation claim, jury duty ). We also assist with severance agreement negotiation and drafting.
• HR and Employee Training (Compliance): Assisting in the development and delivery of mandatory and best-practice employee training programs. This includes HIPAA Privacy and Security training (annual training is a best practice, new hires trained promptly ), Fraud, Waste, and Abuse (FWA) prevention (especially critical for pharmacies participating in Medicare Parts C and D, with training required within 90 days of hire and annually thereafter ), OSHA workplace safety training (e.g., Hazard Communication Standard, infection control, emergency action plans ), and Florida-mandated training such as human trafficking awareness for healthcare professionals (a one-time requirement, often 1-2 hours ).
• Employee Write-ups (Disciplinary Documentation): Guiding you on best practices for creating effective and legally sound disciplinary write-ups. Documentation should be objective, specific about the misconduct or performance deficiency, clearly reference the violated policy or standard, outline the corrective action expected, and specify the consequences of failure to improve or further violations. This aligns with principles of fair and progressive discipline and is vital for defending against unemployment claims or wrongful termination lawsuits.
• Non-Compete Issues: Drafting, reviewing, and litigating non-compete, non-solicitation, and confidentiality agreements for pharmacy staff. We ensure these agreements are enforceable under Florida Statutes §542.335, which requires them to protect legitimate business interests and be reasonable in time, area, and line of business. We also monitor and advise on new legislation, such as the proposed “CHOICE Act” , which could significantly alter Florida’s non-compete landscape by potentially reinforcing employers’ ability to use restrictive covenants, introducing concepts like “covered garden leave agreements,” and imposing new notice requirements.
• EEOC and DOL Compliance: Ensuring your pharmacy’s employment practices comply with federal Equal Employment Opportunity Commission (EEOC) mandates, which prohibit discrimination based on race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age (40 or older), disability, or genetic information. We also advise on compliance with Department of Labor (DOL) regulations, including the Fair Labor Standards Act (FLSA) regarding minimum wage and overtime, and specific programs like the Federal Employees’ Compensation Act (FECA) drug formulary for pharmacies serving federal workers’ compensation patients.

We develop and review essential practice forms to ensure both operational efficiency and legal compliance:

• Patient Intake and History Forms: Ensuring your patient intake forms collect all necessary demographic, medical, insurance, and medication history information efficiently while strictly adhering to HIPAA’s minimum necessary standard and Florida’s patient confidentiality laws. Forms should be clear, easy to understand, and available in multiple languages if serving diverse populations.
• HIPAA Forms (Notice of Privacy Practices, Authorization for Use/Disclosure, Consent): Drafting and implementing clear, compliant Notice of Privacy Practices (NPP) that accurately reflects your pharmacy’s information practices and patient rights. Developing patient authorization forms for uses and disclosures of PHI not otherwise permitted by the Privacy Rule (e.g., certain marketing activities, research). Creating general consent forms for treatment, payment, and healthcare operations (TPO). All forms must meet federal HIPAA and any specific Florida requirements.
• Privacy and Consent Forms (General & Specific Services): Developing tailored informed consent forms for specific pharmacy services such as Medication Therapy Management (MTM) , immunizations (as required by F.S. 465.189, including information about risks, benefits, and reporting to immunization registries ), point-of-care testing (as per F.S. 465.1895, ensuring patients understand the test, its limitations, and follow-up recommendations ), and for specific patient populations. This includes adhering to Florida’s stringent requirements for express and informed consent for prescribing psychotropic medications for children under 13 in the Medicaid program, which necessitates prescriber documentation and a signed attestation provided to the pharmacy (F.S. 409.912(51) ).
• ABN (Advance Beneficiary Notice of Non-coverage): Guiding on the proper and compliant use of Advance Beneficiary Notices (ABNs) for Medicare (Form CMS-R-131) and Medicaid beneficiaries when a service or item may not be considered medically necessary or covered. This includes ensuring patients understand their potential financial liability before services are rendered. We provide guidance on the updated CMS forms and specific instructions for handling ABNs for Dually Eligible Beneficiaries (those with both Medicare and Medicaid), which require specific modifications to the Option Box language on the ABN form.
• Letters of Protection (LOP): Advising on the use, implications, and legal requirements of Letters of Protection (LOPs) when providing pharmacy services to personal injury patients who are deferring payment until a legal settlement or judgment. This includes understanding the LOP as a binding contract, the risks of non-payment if the case is unsuccessful, and the disclosure requirements under recent Florida legislation (e.g., House Bill 837, which mandates LOP disclosure when claiming medical expenses in personal injury cases ).

We conduct expert review and robust negotiation of your Pharmacy Benefit Manager (PBM) contracts. Our focus is on securing favorable reimbursement rates, fair and transparent audit provisions, mitigating the impact of Direct and Indirect Remuneration (DIR) fees, ensuring reasonable network participation terms, and confirming compliance with Florida’s Prescription Drug Reform Act (SB 1550) and other applicable state and federal laws. This includes analyzing requirements for pass-through pricing models and prohibitions on spread pricing unless the PBM passes along the entire amount of any difference to the plan or program. Our team stays abreast of evolving PBM transparency and accountability measures, including the Florida Office of Insurance Regulation’s (OIR) biennial examinations of PBMs , to advocate effectively on your behalf. These examinations systematically review PBM compliance with SB 1550 and other applicable laws, including a detailed review of compliance with sections 626.8825 and 626.8827, Florida Statutes. We help you understand and challenge unfair PBM practices, such as unjustified financial clawbacks (prohibited under certain circumstances by SB 1550 ) and aggressive audit tactics, leveraging statutory protections. This specialized focus is critical, as demonstrated by the emphasis placed on PBM expertise by leading national and state healthcare law firms.

Proactive documentation strategies are key to preventing audits and substantiating claims. We advise on best practices for medical and dispensing documentation to support billing. In the event of an audit, we provide vigorous defense against PBM audits, Medicare and Medicaid recovery audits (conducted by Recovery Audit Contractors (RACs), Medicare Administrative Contractors (MACs), and Unified Program Integrity Contractors (UPICs)), and other commercial payor investigations. We assist in optimizing your revenue cycle management processes, from initial insurance verification and prior authorization to claims submission, denial management, and appeals, all aimed at improving cash flow and reducing lost revenue.

Our services include comprehensive review and negotiation of contracts with all types of payors, ensuring terms are fair, compliant with applicable laws (like Florida’s network adequacy requirements, which must meet or exceed Medicare Part D standards ), and protective of your pharmacy’s financial interests.

We streamline the often burdensome processes of initial provider enrollment and re-credentialing with Medicare, Florida Medicaid, and commercial insurance plans. This includes ensuring all documentation, such as disclosure of Social Security Numbers for owners/operators for Medicaid enrollment , is accurate and timely submitted to avoid delays in participation.

Navigating Medicare and Florida Medicaid reimbursement is a core strength. We help you understand and apply complex payment methodologies, including Actual Acquisition Cost (AAC), Wholesaler Acquisition Cost (WAC), Federal Upper Limit (FUL), and State Maximum Allowable Cost (SMAC) for Florida Medicaid (per AHCA rule 59G-4.251 ). We ensure you understand current professional dispensing fees (e.g., Florida Medicaid’s fee of $10.24 for many claims ). We address reimbursement challenges unique to Long-Term Care (LTC) pharmacy billing in Florida, which often involves complex coordination with facilities and specific payer rules. We also clarify policies for 340B-purchased drugs, which are reimbursed by Florida Medicaid at the actual purchased drug price (not to exceed the 340B ceiling price) plus a dispensing fee. Guidance is also provided on reimbursement for specialized services like clotting factors and practitioner-administered drugs.

If faced with an audit from Medicare Administrative Contractors (MACs), Unified Program Integrity Contractors (UPICs, formerly ZPICs/PSCs), or state Medicaid agencies (like AHCA in Florida ), we provide robust defense. This includes responding to documentation requests, challenging erroneous findings, and managing the entire appeals process for denied claims or adverse audit determinations.

Being placed on prepayment review by Medicare can severely impact cash flow, as payment is withheld until documentation is submitted and approved. We offer immediate assistance to navigate these intensive reviews, whether initiated by MACs or the more stringent UPICs. The objective is to help your pharmacy demonstrate correct billing patterns swiftly, address auditor concerns effectively, and achieve removal from prepayment status as quickly as possible. The gravity of these reviews cannot be overstated; an erroneous or delayed response can prolong the payment suspension, and if fraud is suspected (a common trigger for UPIC reviews), the review can become indefinite, potentially leading to exclusion from federal healthcare programs. Immediate, specialized legal intervention is crucial when a pharmacy receives a prepayment review notice. Our firm provides this critical lifeline, offering rapid response and expert navigation to mitigate financial damage and protect your pharmacy’s participation in vital federal programs.

We advocate for pharmacies in resolving payment disputes with commercial insurance companies, addressing issues such as underpayments, unfair denials based on medical necessity or coding, and contract term misinterpretations.

The 340B Drug Pricing Program offers significant benefits but comes with complex compliance obligations. We provide comprehensive counsel on all aspects of the 340B program, including:

• Assessing eligibility for various covered entity types (e.g., FQHCs, certain hospitals ).
• Navigating the registration process with the Health Resources and Services Administration (HRSA).
• Implementing robust policies and procedures to prevent drug diversion and duplicate discounts (e.g., ensuring 340B drugs are not also subject to Medicaid rebates).
• Structuring compliant contract pharmacy arrangements, including negotiating agreements that benefit both the covered entity and the contract pharmacy while adhering to program rules.
• Managing inventory (virtual vs. physical inventory models) and ensuring auditable records.
• Preparing for and responding to HRSA audits and manufacturer inquiries.
• Advising on Florida Medicaid’s specific rules for billing 340B-acquired drugs and staying informed about the evolving state legislative landscape concerning 340B (e.g., the postponed HB 657 (2025) which aimed to mandate 340B prices for Medicaid pharmacies ). Quarles is a notable firm emphasizing its 340B expertise.

We ensure your marketing practices align with:

• The Florida Drug and Cosmetic Act (F.S. Chapter 499): This Act strictly prohibits false or misleading advertisements for drugs, devices, or cosmetics. It specifically forbids advertising any drug or device as having an effect on a lengthy list of serious conditions (e.g., cancer, diabetes, heart disease) unless the product is FDA-approved for such self-medication indications or the advertisement is directed solely to healthcare professionals.
• Florida Board of Pharmacy Advertising Rules: These rules, found within the broader Florida Bar advertising rules for lawyers (which provide analogous principles for professional advertising), require clarity, truthfulness, and proper identification. For pharmacies, this translates to ensuring any advertising is not deceptive and clearly identifies the pharmacy.
• Federal Trade Commission (FTC) Requirements: The FTC mandates truthfulness, non-deception, and evidence-based substantiation for all advertising claims, with heightened scrutiny for health-related claims. Claims must not be unfair or deceptive under Section 5 of the FTC Act, and misleading claims for drugs and devices are prohibited under Sections 12-15.

Compensating marketers, whether employees or independent contractors, requires careful structuring to avoid violations of the federal Anti-Kickback Statute (AKS), Stark Law, and Florida’s specific anti-referral laws. These include the Florida Patient Brokering Act (F.S. §817.505), which broadly prohibits paying or receiving remuneration for patient referrals, the Florida Anti-Kickback Statute (F.S. §456.054), which defines “kickback” as remuneration to induce referrals for services or items when not tax-deductible as an ordinary expense, and the pharmacy-specific anti-rebate statute (F.S. §465.185), which prohibits paying or receiving any commission, bonus, or kickback for referrals to a pharmacy. We analyze proposed compensation arrangements for compliance, advising on the applicability of safe harbors, such as the bona fide employee safe harbor under the federal AKS, which may permit certain commission structures if specific criteria are met. It is critical to understand the distinction between these laws: the federal AKS is an intent-based criminal statute, requiring proof that remuneration was “knowingly and willingly” offered or received to induce referrals. Conversely, the Stark Law is a strict liability civil statute, meaning an improper referral due to a financial relationship can lead to penalties even without intent to violate the law. This difference significantly impacts compliance planning and defense strategies; for Stark, meticulous adherence to exceptions is key, while for AKS, avoiding any appearance of intent to induce referrals is paramount. We draft marketing employment contracts that clearly define roles, responsibilities, compliant compensation structures, and strict adherence to all legal and ethical standards. Florida’s rules on payments to unlicensed health insurance agents for referrals may also offer analogous principles if marketers are involved in steering patients to services tied to specific insurance reimbursements.

Engaging third-party marketing agencies requires rigorous due diligence. We assist in evaluating potential marketing partners by reviewing their compliance programs, assessing their understanding of healthcare regulations (especially HIPAA and anti-kickback laws), and checking for reputational risks. It is crucial to remember that a pharmacy cannot engage a third party to perform marketing activities that the pharmacy itself is prohibited from doing. We draft and negotiate contracts with these agencies that include clear scopes of work, robust compliance obligations, indemnification clauses to protect the pharmacy, and stringent provisions for protecting any PHI shared, ensuring alignment with your pharmacy’s ethical and legal standards.

We guide your pharmacy in complying with FTC Act Sections 5 (prohibiting unfair or deceptive acts or practices) and Sections 12-15 (prohibiting misleading claims for food, drugs, devices, services, or cosmetics). This includes ensuring all health-related advertising claims are truthful, not misleading, and backed by competent and reliable scientific evidence. Disclosures in online advertising must be clear and conspicuous. We also advise on compliance with FTC rules regarding endorsements, influencers, and consumer reviews, ensuring any material connections are disclosed and reviews are genuine.

Our firm conducts comprehensive reviews of all your marketing collateral – including websites, brochures, print ads, social media content, and digital campaigns – to ensure full compliance with Florida and federal laws, including HIPAA, FTC guidelines, and pharmacy-specific advertising rules. For Internet Pharmacies, we ensure your website meets Florida Board of Pharmacy requirements per F.S. §465.0197 and FAC 64B16-28.900, such as displaying licensure information, providing a toll-free number for patient communication with a pharmacist, ensuring the pharmacy is open at least 6 days a week for a minimum of 40 hours, and maintaining an up-to-date policy and procedure manual available for inspection.

Understanding the distinction between “marketing” communications and communications for treatment, payment, or healthcare operations (TPO) is crucial under HIPAA. HIPAA defines marketing broadly as a communication about a product or service that encourages its purchase or use. Generally, a patient’s explicit, written authorization is required before their Protected Health Information (PHI) can be used or disclosed for such marketing purposes, especially if the pharmacy receives financial remuneration from a third party for making the communication. However, certain communications are not considered marketing and do not require prior patient authorization. These include:

• Face-to-face communications made by the pharmacy to an individual.
• Promotional gifts of nominal value.
• Communications to describe health-related products or services provided by the pharmacy itself.
• Communications for treatment purposes, such as refill reminders (provided any remuneration is reasonably related to the cost of the communication) or recommending alternative therapies.
• Communications for case management or care coordination. We help you navigate these definitions to ensure compliance, identifying when authorization is mandatory and when communications fall under permissible TPO exceptions.

Managing your online reputation is important, but responses to patient reviews must be HIPAA compliant. We advise on strategies for responding to online reviews without acknowledging an individual’s patient status or disclosing any PHI. Best practices include speaking in general terms about pharmacy policies, offering to take the conversation offline to address concerns privately, and never confirming that the reviewer is indeed a patient, even if the reviewer self-discloses this information. It is also important to be aware of the Consumer Review Fairness Act (CRFA), which protects consumers’ ability to share honest opinions.

We assist Florida pharmacies in developing, implementing, and maintaining robust compliance programs tailored to their specific operations. This involves ensuring adherence to a multitude of laws and regulations, including:

• Florida Board of Pharmacy Regulations: F.S. Chapter 465 (Florida Pharmacy Act) and FAC 64B16 (Board of Pharmacy Rules) governing pharmacist licensing, pharmacy permits, standards of practice, pharmacy technicians, patient counseling, compounding, record-keeping, and disciplinary actions.
• DEA Regulations: Federal rules for controlled substances, including registration, record-keeping, inventory, security, dispensing, and disposal.
• FDA Rules: Regulations pertaining to drug safety, labeling, and manufacturing.
• Florida Drug and Cosmetic Act (F.S. Chapter 499): Rules on drug storage, handling, labeling, advertising, and wholesale distribution.
• Florida Controlled Substances Act (F.S. Chapter 893): State laws on controlled substance scheduling, prescribing, dispensing, and record-keeping. Our compliance programs are designed to incorporate the seven core elements recommended by the Office of Inspector General (OIG), including written policies and procedures, a designated compliance officer/committee, effective training, open lines of communication, internal monitoring/auditing, enforcement of standards, and prompt response to detected offenses.

Navigating the complex web of fraud and abuse laws is critical for pharmacies. We provide expert counsel on:

• Anti-Kickback Statute (AKS): Both the federal AKS (42 U.S.C. § 1320a-7b(b)) and Florida’s state-level prohibitions, including the Florida Anti-Kickback Statute (F.S. §456.054) and the Patient Brokering Act (F.S. §817.505). These laws broadly prohibit offering, paying, soliciting, or receiving “remuneration” (anything of value) to induce or reward referrals of patients or business payable by federal or state healthcare programs. The federal AKS is an intent-based criminal statute, requiring that one “knowingly and willingly” engages in the prohibited conduct.
• Stark Law (Physician Self-Referral Law): The federal Stark Law (42 U.S.C. § 1395nn) prohibits physicians from referring Medicare or Medicaid patients for certain “designated health services” (DHS) – which include outpatient prescription drugs – to entities with which the physician (or an immediate family member) has a financial relationship, unless an exception applies. Unlike the AKS, Stark Law is a strict liability statute; intent to violate the law is not a prerequisite for a violation, making meticulous compliance with its complex exceptions paramount. This distinction is crucial: an arrangement might inadvertently violate Stark Law and lead to significant penalties even without improper intent, whereas an AKS violation typically requires proof of knowing and willful misconduct. This nuanced understanding informs our approach to structuring compliant arrangements and defending against allegations.
• Safe Harbor Exceptions (AKS & Stark): We analyze and structure business arrangements to fit within applicable statutory and regulatory safe harbors under the AKS (e.g., bona fide employment, space/equipment rental, personal services and management contracts ) and exceptions under Stark Law (e.g., in-office ancillary services, bona fide employment relationships, rental of office space/equipment ).

• HIPAA Compliance (Privacy, Security, Breach Notification Rules): We offer comprehensive guidance on all aspects of HIPAA, including safeguarding PHI and ePHI, ensuring patient rights (such as the right to access and amend their records ), drafting and implementing compliant Business Associate Agreements, conducting mandatory security risk assessments, developing staff training programs, and establishing procedures for responding to and notifying of data breaches in accordance with the Breach Notification Rule.
• Board Regulations (Record Requests, Informed Consents): Ensuring compliance with Florida Board of Pharmacy rules regarding patient access to pharmacy records and the proper obtaining and documentation of informed consent for various pharmacy services and disclosures. Florida law requires public records maintained by the Department of Health to be available for review unless confidential or exempt.

We provide robust representation for pharmacies undergoing audits by:

• PBMs: Including navigating the Florida Office of Insurance Regulation’s (OIR) biennial examinations of PBMs, which scrutinize compliance with Florida’s Prescription Drug Reform Act (SB 1550).
• Florida Board of Pharmacy: Responding to inspections and investigations concerning compliance with pharmacy laws and rules.
• DEA: Handling unannounced audits, inspections, and investigations related to controlled substance handling, recordkeeping, and security.
• Medicare/Medicaid: Defending against audits by MACs, RACs, UPICs, and state Medicaid Fraud Control Units (MFCUs).
• Other Insurers: Addressing audits from commercial payors. Our services include proactive audit preparedness, such as conducting mock audits, reviewing record-keeping practices (a common area for “red flags” ), and assessing overall compliance programs.

Should disputes escalate to litigation, whether related to regulatory enforcement, contract breaches, employment matters, or other pharmacy-related issues, our firm provides experienced litigation support and tenacious representation to protect your interests.

We provide comprehensive legal support for both buy-side and sell-side pharmacy transactions, from initial valuation considerations to post-closing integration. A critical understanding is that pharmacy transactions are unique; traditional corporate techniques and form documents are often insufficient due to the myriad of licensing, regulatory, and PBM contract considerations specific to this sector.

Thorough due diligence is paramount. For buyers, we conduct an in-depth examination of the target pharmacy’s financial health, operational compliance (including review of licenses, permits, PBM contracts, and controlled substance handling), legal status (contracts, litigation history), and real estate matters. For sellers, we assist in preparing for the due diligence process, organizing records, and identifying and addressing potential issues proactively to ensure a smoother transaction.

We draft and negotiate detailed Asset Purchase Agreements or Stock Purchase Agreements specifically tailored to pharmacy transactions. These agreements address critical elements such as the precise assets/liabilities being transferred (including inventory valuation, particularly for controlled substances), representations and warranties related to compliance, indemnification provisions for regulatory actions, and covenants regarding post-closing operations.

Successfully integrating a newly acquired pharmacy—or winding down operations after a sale—is a complex process fraught with potential pitfalls if not managed correctly. Unlike many general business mergers, pharmacy integration involves navigating a labyrinth of state and federal regulations that can halt operations if mishandled. For instance, Florida law is unequivocal: pharmacy permits are not transferable]. A change in ownership, often determined by a change in the Federal Employer Identification Number (FEIN) , typically requires the buyer to file a new permit application, undergo inspections, and meet all current licensing standards. This means the acquiring entity cannot simply step into the seller’s existing permits. Similarly, DEA registrations are location and owner-specific and require new applications or proper transfer procedures. PBM contracts also have specific change of ownership (CHOW) notification and re-credentialing requirements that, if not followed, can lead to network termination and loss of revenue. Furthermore, the transfer of controlled substance inventory must be meticulously documented, often requiring a complete inventory on the date of transfer (serving as the seller’s final and buyer’s initial inventory) and the use of DEA Form 222 for Schedule II substances. Patient records must be transferred in a HIPAA-compliant manner. Recognizing these high stakes, our firm provides specialized post-merger integration legal support. We develop detailed checklists and action plans covering:

• Operations: Merging or standardizing Policies and Procedures (P&Ps), operational workflows, and quality assurance programs.
• Licenses & Permits: Guiding the new owner through applications for Florida Board of Pharmacy permits, DEA registrations, and local business licenses. Ensuring all CHOW notifications are correctly filed with the BOP and other agencies.
• PBM Contracts: Managing CHOW notifications, re-credentialing, and negotiating any necessary amendments to PBM contracts for the new entity.
• Controlled Substances: Overseeing the legal requirements for inventory, transfer, and record-keeping of controlled substances.
  Patient Records: Ensuring HIPAA-compliant transfer, integration, and continued secure maintenance of patient records.
• IT Systems: Advising on the legal aspects of merging or migrating pharmacy management software, EHRs, and other IT infrastructure, focusing on data security, integrity, and HIPAA compliance.
• Staff: Managing employee contracts, benefits, and HR policy integration for the combined workforce.
• Real Estate: Handling lease assignments, new lease negotiations, or property transfer documentation. This proactive and detailed approach to post-transaction integration is essential for a seamless transition and the continued compliant operation of the pharmacy.

We ensure all legally required notices for buying or selling a pharmacy are timely and accurately filed with the Florida Board of Pharmacy (e.g., notification of change of ownership, change in prescription department manager or consultant pharmacist of record within 10 days per F.S. 465.022(10) ), the DEA (e.g., at least 14 days prior notice for transfer of controlled substances ), and other relevant state and federal agencies.

We ensure the transaction structure itself complies with all applicable state and federal laws, including Florida Board of Pharmacy oversight regarding bona fide transfers of ownership, designed to prevent circumvention of administrative prosecution].

We assist in reviewing and managing existing employee contracts during a transition, advising on assignments, new offers, or terminations. We also ensure the HIPAA-compliant transfer and secure management of all patient records throughout the transaction and integration process.

We provide legal counsel on the integration or expansion of pharmacy services post-acquisition. This includes ensuring that PBM contracts are updated to reflect any changes in service offerings or network configurations, and that network adequacy requirements under Florida law (which often reference Medicare Part D standards) are met.

While past results do not guarantee future outcomes, our experience speaks to our capabilities. We have, for example:

• Successfully guided numerous Florida pharmacies through the complex initial licensure and DEA registration process, including proactively managing common start-up delays to ensure timely and compliant openings.
• Assisted multi-location pharmacy groups in comprehensive reviews and renegotiations of PBM contracts, leading to more favorable terms and a clearer understanding of reimbursement mechanisms.
• Effectively defended community and specialty pharmacies in challenging Florida Board of Pharmacy and DEA audits and investigations, protecting their licenses and operational viability.
• Counseled pharmacies through intricate buy-sell transactions, from initial due diligence and contract negotiation to meticulous post-merger integration, ensuring seamless transitions and continued regulatory compliance.
• Developed and implemented robust, customized compliance programs for pharmacies of all sizes, significantly reducing their risk of violations related to HIPAA, Fraud, Waste & Abuse, Stark Law, and the Anti-Kickback Statute.

Pharmacies operate at the intersection of healthcare and business, requiring legal counsel that is both highly specialized in pharmacy law and broadly adept in corporate and transactional matters. We understand that a standard business contract or a generic compliance plan is insufficient for the unique challenges you face. Our approach is to provide “specialized generalist” counsel – every piece of advice, every document drafted, and every strategy developed is informed by its specific impact on your pharmacy’s operations, compliance, and profitability. This holistic perspective ensures that all your legal needs are met cohesively and effectively.

We pride ourselves on anticipating challenges before they arise. Whether it’s understanding the nuances of Florida’s BOP notification rules for delayed openings , the critical distinctions in intent standards between the Anti-Kickback Statute and Stark Law , or the imperative for immediate, expert intervention in Medicare prepayment reviews , our firm is dedicated to providing foresight and strategic solutions. We believe in empowering you with the knowledge and tools to navigate the regulatory landscape proactively.

We view our relationship with each client as a long-term partnership. Our goal is not only to resolve your immediate legal issues but also to educate and empower you to make informed decisions that strengthen your pharmacy for the future. We strive to demystify complex legal requirements and work collaboratively to achieve your business objectives.

Our attorneys live and breathe Florida’s pharmacy laws, including the Florida Pharmacy Act (Chapter 465), Drug and Cosmetic Act (Chapter 499), Controlled Substances Act (Chapter 893), and Florida Board of Pharmacy rules (FAC 64B16). We continuously monitor legislative changes, Board pronouncements, and AHCA enforcement trends to keep your pharmacy prepared.

From launch to growth, compliance, and strategic transactions, we offer a full spectrum of legal services for your pharmacy’s entire lifecycle.

We believe informed clients make the best decisions. We educate you on the laws affecting your practice, empowering confident, proactive operations.

We identify and address potential legal and compliance pitfalls before they become costly problems, safeguarding your license, finances, and reputation.